In this issue:
2025 update to EAU prostate cancer guidelines
Australian Clinical Practice Guidelines for the early detection of prostate cancer
Mortality risk with active avoidance of screening
BARCODE 1: Targeted screening based on polygenic risk score
What is the optimal interval to evaluate PSA post-prostatectomy?
TGA approves export only abiraterone acetate products
PBS listing of abiraterone acetate + prednisolone under evaluation
Dual medicine labelling requirement ends in May
Personalised lighting intervention promising for cancer-related fatigue
Former US President Biden diagnosed with metastatic prostate cancer
PCFA’s Walk for Him event on during Men's Health Week
Improved prostate cancer detection with transperineal biopsy
COVID-19 resources
Conferences & Workshops
Please login below to download this issue (PDF)